Clinical Trial Update: A Study to Evaluate the Long-term Safety of Patients With Advanced Lymphoid Leukemia Who Have Been Previously Administered With UCART19 [Phase 1]

View source ↗

Summary

A Phase 1 long-term safety study of UCART19 in patients with advanced lymphoid leukemia is ongoing (status: ACTIVE_NOT_RECRUITING).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• UCART19

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Advanced Lymphoid Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING